None

Tolterodine ER vs Fesoterodine for Overactive Bladder

Is there a benefit to switching from tolterodine ER to fesoterodine for overactive bladder therapy -- and are dosage and patient age significant? BMC Urology

Fesoterodine curbs nocturnal urgency: study

NEW YORK (Reuters Health) - The antimuscarinic fesoterodine (Toviaz) was statistically more likely than placebo to decrease nocturnal urgency (and nocturia, a secondary outcome) in a large randomi...

Gas Chromatography Device

Analytical Pixels Technology has introduced the GCAP, a gas chromatography device designed for a variety of industrial and petrochemical applications.Read more about Gas Chromatography DeviceComments

Chromatography Consumables

Thermo Fisher Scientific Inc. announced new chromatography consumables at Pittcon 2013. Among the consumables are new columns designed for improved analysis of chemical compounds.Read more about Chrom...

Mom – the Ultimate Chromatographer: Insights into HPLC and GC Chromatography

(PRWEB) May 09, 2013 Think your mom knows nothing about chromatography? Think again. We all know that moms play a valuable role in our lives. They feed us when we’re hungry, pick us up wh...

Study Shows Higher Dose Of Toviaz (fesoterodine fumarate) Offers Greater Efficacy In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder

NEW YORK--(BUSINESS WIRE)--Jan 24, 2013 - Pfizer Inc. (NYSE: PFE) announced today that a Phase 4 study assessing the efficacy and safety of Toviaz® (fesoterodine fumarate) 8 mg once daily in patie...

Agilent Launches Chromatography and Spectroscopy Catalog

The 2013 Essential Chromatography and Spectroscopy Catalog helps readers easily navigate Agilent’s growing portfolio of general chromatography, sample preparation, GC and GC/MS, LC and LC/MS, and sp...

Liquid Chromatography System Enhances Biopharmaceutical Workflows

Thermo Fisher Scientific Inc. featured its Dionex UltiMate 3000 biocompatible rapid separation (BioRS) liquid chromatography system at Pittcon 2013. The system is designed to combine the performance a...

Fesoterodine in randomised clinical trials: an updated systematic clinical review of efficacy and safety.

INTRODUCTION AND HYPOTHESIS: This is a systematic review of clinical data assessing the safety, efficacy and tolerability of fesoterodine in randomised control trials (RCTs) in the treatment of overac...

Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder.

ABSTRACT: BACKGROUND: Fesoterodine is an antimuscarinic for the treatment of overactive bladder, a syndrome of urgency, with or without urgency urinary incontinence (UUI), usually with increased dayti...

Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial.

Study Type - Therapy (RCT)
 Level of Evidence 1b OBJECTIVE: To show the superior efficacy of fesoterodine over tolterodine extended release (ER) in a placebo-controlled overactive bladder (OAB) tr...

Fesoterodine stress degradation behavior by liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry.

In the present study, a rapid validated stability-indicating LC method was established and comprehensive stress testing of fesoterodine was carried out according to ICH guidelines. Fesoterodine was su...

Effects of drug cessation after flexible-dose fesoterodine in patients with overactive bladder.

OBJECTIVE: To determine the course of overactive bladder (OAB) symptoms after 4 weeks of no treatment following a 12-week study of the efficacy and safety of flexible-dose fesoterodine in patients wit...